Summary
Atorvastatin therapy may delay the loss of beta-cell function in patients with recent-onset type 1 diabetes mellitus. This article discusses the multicenter, randomized, placebo-controlled Diabetes and Atorvastatin [DIATOR] trial.
- Lipid Disorders
- Diabetes & Endocrinology Clinical Trials
- Diabetes Mellitus
- © 2010 MD Conference Express